Search
Patexia Research
Case number 2017-1786

Luitpold Pharmaceuticals, Inc. v. Pharmacosmos A/S > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 LUITPOLD PHARMACEUTICALS, INC. v. PHARMACOSMOS A/S [ORDER] [nonprecedential] (0)
May 21, 2018 13 Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [523105] [17-1715, 17-1725, 17-1786] [JAB] [Entered: 05/21/2018 09:55 AM] (0)
Apr 12, 2018 12 ORDER filed dismissing cross-appeal. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [512757] [SJ] [Entered: 04/12/2018 09:34 AM] (0)
Apr 11, 2017 11 Certified list from the United States Patent and Trademark Office. Service: 04/11/2017 by email. [423837] [FMS] [Entered: 04/13/2017 02:10 PM] (0)
Mar 24, 2017 4 Docketing Statement for the Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418743] [Paul Ragusa] [Entered: 03/24/2017 01:18 PM] (0)
Mar 24, 2017 5 Entry of appearance for Lisa Kole as of counsel for Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418749] [Lisa Kole] [Entered: 03/24/2017 01:22 PM] (0)
Mar 24, 2017 6 Entry of appearance for Steven Lendaris as of counsel for Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418752] [Steven Lendaris] [Entered: 03/24/2017 01:24 PM] (0)
Mar 24, 2017 7 Entry of appearance for Jennifer C. Tempesta as of counsel for Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418754] [Jennifer Tempesta] [Entered: 03/24/2017 01:26 PM] (0)
Mar 24, 2017 8 NOTICE OF DEFICIENCY: The certificate of interest Document No. [3] filed by Cross-Appellant Pharmacosmos A/S in 17-1786 is incomplete [see question 2] and therefore cannot be accepted for filing at this time. Question 2 may not be left blank; if applicable, "none" may be used. Additionally, please ensure all future filings are entirely text searchable. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [418766] [CMP] [Entered: 03/24/2017 01:46 PM] (0)
Mar 24, 2017 9 Corrected Certificate of Interest for the Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418783] [Paul Ragusa] [Entered: 03/24/2017 02:04 PM] (0)
Mar 24, 2017 10 Note to file: The following cases are associated:17-1715 Lead with 17-1725 Consolidated, 17-1786 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [418870] [17-1715, 17-1725, 17-1786] [JCA] [Entered: 03/24/2017 04:16 PM] (0)
Mar 24, 2017 2 Entry of appearance for Paul A. Ragusa as principal counsel for Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418740] [Paul Ragusa] [Entered: 03/24/2017 01:16 PM] (1)
Mar 24, 2017 3 Certificate of Interest for the Cross-Appellant Pharmacosmos A/S. Service: 03/24/2017 by email. [418741] [Paul Ragusa] [Entered: 03/24/2017 01:17 PM] (0)
Mar 14, 2017 1 Appeal docketed. Received: 03/08/2017. [415168] Certified List due on 04/24/2017. [FMS] [Entered: 03/14/2017 09:45 AM] (8)
Menu